Show simple item record

dc.contributor.authorLeete, P
dc.date.accessioned2023-12-19T16:05:51Z
dc.date.issued2023-09-21
dc.date.updated2023-12-19T15:50:57Z
dc.description.abstractAIMS: This review aims to introduce research in the pancreas to a broader audience. The pancreas is a heterocrine gland residing deep within our abdominal cavity. It is the home to our islets, which play a pivotal role in regulating metabolic homeostasis. Due to its structure and location, it is an impossible organ to study, in molecular detail, in living humans, and yet, understanding the pancreas is critical if we aim to characterise the immunopathology of type 1 diabetes (T1D) and one day prevent the triggering of the autoimmune attack associated with ß-cell demise. METHODS: Over a 100 years ago, we began studying pancreatic histology using cadaveric samples and clever adaptations to microscopes. As histologists, some may say nothing much has changed. Nevertheless, our microscopes can now interrogate multiple proteins at molecular resolution. Images of pancreas sections are no longer constrained to a single field of view and can capture a thousands and thousands of cells. AI-image-analysis packages can analyse these massive data sets offering breakthrough findings. CONCLUSION: This narrative review will provide an overview of pancreatic anatomy, and the importance of research focused on the pancreas in T1D. It will range from histological breakthroughs to briefly discussing the challenges associated with characterising the organ. I shall briefly introduce a selection of the available global biobanks and touch on the distinct pancreatic endotypes that differ immunologically and in ß-cell behaviour. Finally, I will introduce the idea of developing a collaborative tool aimed at developing a cohesive framework for characterising heterogeneity and stratifying endotypes in T1D more readily.en_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.format.extente15228-
dc.format.mediumPrint-Electronic
dc.identifier.citationVol. 40(12), article e15228en_GB
dc.identifier.doihttps://doi.org/10.1111/dme.15228
dc.identifier.grantnumber22/0006378en_GB
dc.identifier.urihttp://hdl.handle.net/10871/134831
dc.identifierORCID: 0000-0002-4013-0040 (Leete, Pia)
dc.language.isoenen_GB
dc.publisherWiley / Diabetes UKen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/37735524en_GB
dc.rights© 2023 The Authors. Diabetic Medicine published by John Wiley & Sons on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.en_GB
dc.subjectT1Den_GB
dc.subjectType 1 diabetesen_GB
dc.subjectbiobanksen_GB
dc.subjectendotypesen_GB
dc.subjectisletsen_GB
dc.subjectpancreasen_GB
dc.subjectstratificationen_GB
dc.titleType 1 diabetes in the pancreas: A histological perspectiveen_GB
dc.typeArticleen_GB
dc.date.available2023-12-19T16:05:51Z
dc.identifier.issn0742-3071
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available on open access from Wiley via the DOI in this recorden_GB
dc.identifier.eissn1464-5491
dc.identifier.journalDiabetic Medicineen_GB
dc.relation.ispartofDiabet Med, 40(12)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_GB
dcterms.dateAccepted2023-09-17
dc.rights.licenseCC BY-NC-ND
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-09-21
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-12-19T15:58:18Z
refterms.versionFCDVoR
refterms.dateFOA2023-12-19T16:05:56Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. Diabetic Medicine published by John Wiley & Sons on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Diabetic Medicine published by John Wiley & Sons on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.